China Resources Boya Bio-pharmaceutical Group Co.,Ltd

¥14.25As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300294Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (9.64%)
Div yield 1.57%
ROE (2.25%)
Biotechnology
Beta (5Y) 0.42
PE TTM —
TSR TTM (43.33%)
Mkt cap ¥7.186B
ROIC 0.40%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥17
18.18%
32.12%
Hold 11|4|2|9|10
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.17
0.17
0.17
0.18
6.01%
4.36%
(5.48%)
4.29%
Revenue¥B
0.937
0.955
0.977
1.018
13.90%
9.53%
9.93%
13.75%
Peers (US$1.077B)
Cap (US$)
PE
1.086B
26.50x
Capital
TTM
5Y
10Y
Leveragex
0.135
0.153
0.122
EBIT/Intx
1.121
0.188
0.188
Own earn%
(31.81)
(62.74)
(55.67)
Sh yield%
32.73
17.40
20.70
Owners
Insiders/Inst%
10.00
68.38
Short interest%
5.91
SBC / revenue%
4.57
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
12–23
$1 testx
−0.1
Incr. ROIC%
13